Data Innovations, a global provider of clinical laboratory middleware software, has been acquired by Battery Ventures.
According to a press release, the transaction, whose amount remained undisclosed, will enable the company to drive continued organic growth into new and existing market segments, and pursue acquisition opportunities.
In conjunction with the acquisition, Battery Ventures’ Dave Tabors and Chelsea Stoner, join Data Innovation’s board of directors, along with new CEO Mike Epplen, who is an experienced healthcare software executive with more than 17 years of technical, operational and sales experience in a variety of sectors.
Founded in 1989, Data Innovations is a global clinical and blood laboratory middleware company with a focus solely on laboratory data management. With offices in the United States, Belgium, Brazil, China, France, and the United Kingdom, DI currently has over 6,500 systems in more than 65 countries.
Products include the Instrument Manager (IM) and Laboratory Production Manager (LPM) for pre-analytical, analytical, and post-analytical sample processing and non analytical tasks such as equipment maintenance. It supports roughly 1,000 different instruments, automation systems, and information systems.